Related Experiment Video
Updated: Jul 16, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Bleeding peptic ulcer--risk factors for rebleeding and sequential changes in endoscopic findings
1Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Hypovolemic shock, visible non-bleeding vessels, and adherent clots are key predictors of peptic ulcer rebleeding. Most rebleeding occurs within 96 hours of admission, making this observation period crucial for patient management.
Area of Science:
- Gastroenterology
- Endoscopy
- Internal Medicine
Background:
- Peptic ulcer bleeding is a significant cause of morbidity.
- Identifying risk factors for rebleeding is crucial for effective patient management.
- Endoscopic findings can predict the likelihood of rebleeding.
Purpose of the Study:
- To determine risk factors for rebleeding in peptic ulcers.
- To assess the residual risk of rebleeding after initial management.
- To analyze endoscopic changes in ulcers that rebled.
Main Methods:
- Prospective study of 452 patients with upper gastrointestinal bleeding.
- Emergency endoscopy performed within 24 hours of admission.
- Multivariate analysis of clinical, laboratory, and endoscopic variables in 204 patients with ulcer bleeding.
Main Results:
- Hypovolemic shock, non-bleeding visible vessels, and adherent clots independently predicted rebleeding (p < 0.05).
- Non-bleeding visible vessels were the strongest predictor of rebleeding.
- 94.1% of rebleeding episodes occurred within 96 hours of admission, with residual risk < 1% thereafter.
Conclusions:
- Hypovolemic shock, non-bleeding visible vessels, and adherent clots are significant predictors of peptic ulcer rebleeding.
- Observation for 96 hours post-admission is sufficient to identify most rebleeding episodes.
- Endoscopic findings of visible vessels or adherent clots at follow-up originate from ulcers with initial major stigmata.
More Related Videos
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
04:08Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Complications